There are no items in your cart
Add More
Add More
Item Details | Price |
---|
Our Real-World Research service focuses on generating evidence from real-world settings, providing critical insights into how interventions, treatments, and public health programs perform outside the controlled environment of clinical trials.
What We Offer:
Observational Studies: Design and conduct prospective and retrospective studies using real-world data (RWD) to assess the safety, effectiveness, and impact of interventions.
Registries & Cohort Studies: Establish and manage patient registries and cohort studies that follow patients over time to gather long-term data on outcomes and quality of life.
Real-World Evidence (RWE) Generation: Analyze healthcare data, including electronic health records (EHRs), insurance claims, and patient-reported outcomes (PROs), to generate real-world evidence.
Comparative Effectiveness Research (CER): Compare the outcomes of different healthcare interventions or treatments in routine clinical practice to inform decision-making and policy.
Example: We conducted a real-world observational study to evaluate the effectiveness of a new asthma treatment in a diverse patient population, providing valuable data that informed treatment guidelines.Our Data Management & Statistical Analysis service ensures that your research data is accurately collected, managed, and analyzed. We provide cutting-edge data solutions and statistical expertise to help you derive meaningful insights from your research.
What We Offer:
Data Management Systems: Implement electronic data capture (EDC) systems and databases that ensure secure, accurate, and efficient data collection.
Data Cleaning & Validation: Ensure that your data is free from errors and inconsistencies before analysis.
Advanced Statistical Analysis: Use state-of-the-art statistical methods to analyze study results, including regression analysis, survival analysis, and more.
Interpretation & Reporting: Provide clear, actionable reports that summarize key findings and their implications for practice or further research.
Example: For a longitudinal public health study, we provided robust data management and conducted advanced statistical analyses to identify long-term trends in population health outcomes.
Our literature review & evidence synthesis service helps you gather and synthesize existing scientific research to inform your study design, support grant applications, or guide policy development.
What We Offer:
Systematic Literature Reviews: Conduct comprehensive reviews to identify relevant studies, summarize evidence, and assess gaps in current knowledge.
Meta-Analysis: Combine data from multiple studies to provide a more precise estimate of treatment effects or other outcomes.
Rapid Evidence Synthesis: Provide quick turnaround reviews to inform urgent healthcare decisions or emerging research areas.
Narrative Reviews: Summarize research findings and trends in a more qualitative format, tailored to the needs of policymakers or stakeholders.
Example: We conducted a systematic review of interventions to reduce healthcare-associated infections, providing critical insights for policy development in hospital settings.
Navigating the complex regulatory landscape is essential for ensuring that your research complies with local, national, and international standards. Our Regulatory & Ethical Compliance Consulting service provides expert guidance throughout your project.
What We Offer:
Regulatory Submissions: Assist with preparing and submitting applications to regulatory bodies (e.g., FDA, EMA) to ensure your research is approved without delays.
Ethical Review Support: Help prepare documents for Institutional Review Boards (IRBs) or Ethics Committees (ECs) to obtain ethical approval for your study.
Informed Consent Processes: Ensure that your study adheres to ethical standards in obtaining informed consent from participants, including vulnerable populations.
Compliance Audits: Conduct audits to ensure ongoing compliance with regulatory standards and ethical guidelines throughout the study’s lifecycle.
Example: We guided a pharmaceutical company through the regulatory approval process for a global clinical trial, ensuring compliance with both FDA and EMA standards.
Effective communication of your research findings is essential for maximizing its impact. Our Scientific Writing & Dissemination service helps you craft high-quality publications and presentations that share your research with the global scientific community.
What We Offer:
Manuscript Preparation: Write and edit manuscripts for submission to peer-reviewed journals, ensuring clarity, accuracy, and adherence to journal guidelines.
Conference Abstracts & Posters: Develop abstracts and create impactful posters or presentations for scientific conferences.
Grant Writing: Provide expert support for writing grant proposals that clearly articulate your research goals and methodology to secure funding.
Knowledge Translation: Help translate scientific findings into policy briefs, white papers, or other formats suitable for policymakers and stakeholders.
Example: We assisted a research team in preparing a manuscript for publication in a high-impact medical journal, resulting in broad dissemination of their findings on novel therapeutic approaches.
Our Health Economics & Outcomes Research (HEOR) service helps you understand the economic and clinical value of healthcare interventions. We provide evidence to support healthcare decision-making, reimbursement strategies, and policy development.
What We Offer:
Cost-Effectiveness Analysis: Evaluate the cost-effectiveness of new treatments, therapies, or public health interventions.
Budget Impact Modeling: Assess the financial impact of introducing new technologies or treatments into healthcare systems.
Patient-Reported Outcomes: Measure and analyze patient-reported outcomes (PROs) to assess the impact of healthcare interventions on quality of life.
Comparative Effectiveness Research: Compare the outcomes of different interventions to inform clinical decision-making and healthcare policy.
Example: We conducted a cost-effectiveness analysis of a new drug therapy for multiple sclerosis, providing crucial evidence to support its reimbursement by healthcare providers.